Induction Murine Models of Chronic Fatigue Syndrome by Brucella abortus Antigen Injections: Is Anemia Induced or Not?
Moriya, Junji, He, Qiang, Uenishi, Hiroaki et al. · BioMed research international · 2015 · DOI
Quick Summary
Researchers injected mice with bacterial antigens from Brucella abortus to create an animal model of ME/CFS. They found that at high doses, the injections caused temporary anemia (low red blood cells), but at moderate doses, anemia did not develop. Importantly, in both groups, the mice showed persistent low activity levels for weeks after treatment stopped, suggesting the injections could trigger lasting fatigue-like symptoms without necessarily causing anemia.
Why It Matters
This research demonstrates that bacterial antigen exposure can produce persistent fatigue-like symptoms in animal models independent of anemia, supporting the hypothesis that post-infectious triggers may contribute to ME/CFS pathogenesis. The moderate-dose protocol without anemia induction may better reflect human disease and could serve as a tool for testing treatments targeting fatigue mechanisms rather than hematologic dysfunction.
Observed Findings
High-dose BA antigen (1×10¹⁰ particles/mouse) induced anemia within 2 weeks with substantial recovery by study end
Moderate-dose BA antigen (alternating 1×10⁸ and 1×10⁹ particles/mouse) did not induce anemia
Running wheel activity remained very low in both dosing groups through 6 weeks post-final injection
Persistent activity reduction occurred independently of anemia status
Inferred Conclusions
Moderate-dose BA antigen injection produces a CFS-relevant animal model with persistent fatigue-like symptoms without hematologic complications
Persistent fatigue-like symptoms can be dissociated from anemia induction, suggesting distinct pathophysiologic mechanisms
Bacterial antigen exposure may be a viable post-infectious trigger for establishing CFS-like phenotypes in preclinical research
Remaining Questions
What are the immune and inflammatory signatures (cytokines, immune cell activation) induced by BA antigen at each dosing level?
What neurological, metabolic, or mitochondrial changes underlie the persistent activity reduction?
How do these murine fatigue-like symptoms relate to specific human ME/CFS features such as post-exertional malaise or cognitive impairment?
What This Study Does Not Prove
This study does not prove that Brucella infection causes human ME/CFS, nor does it establish the mechanisms by which antigen exposure produces fatigue symptoms. The observation of low activity does not confirm this is truly analogous to human ME/CFS fatigue, post-exertional malaise, or associated symptoms like cognitive dysfunction. It also cannot determine whether anemia is necessary or irrelevant to CFS pathogenesis in humans.